EUVIMEDEUVIMED entdecken
Crossref

COVID-19 and pharmaceutical sales in Karaman, Turkey (2019–2021): a hierarchical ATC analysis

Aytac Kocabas iD, Mehmet Cabir Akkoyunlu iD

Expert Review of Pharmacoeconomics & Outcomes Research · 01.11.2026 · 1-14

DOI: 10.1080/14737167.2026.2755202 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Expert Review of Pharmacoeconomics & Outcomes Research, online erschienen am 01.11.2026. Verfasst von Aytac Kocabas und 1 weiteren Autor:innen. Beteiligte Einrichtung: Biology Department, Faculty of Science, Karamanoğlu Mehmetbey University, Karaman, Turkey. Die Arbeit nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The COVID-19 pandemic altered pharmaceutical consumption, but most analyses aggregated sales at broad therapeutic levels, masking category-level variation. Evidence from middle-income countries remains limited. RESEARCH DESIGN AND METHODS: This retrospective study analyzed pharmaceutical sales from 10 community pharmacies and one hospital pharmacy unit in Karaman, Turkey (2019-2021). Products were consolidated using ATC code, yielding 552 products across five ATC levels (m = 14-552). Paired t-tests, blocked and unrestricted ANOVA, Friedman tests, and Wilcoxon comparisons were performed with Benjamini-Hochberg (BH) and Bonferroni corrections. RESULTS: Aggregate sales declined significantly at Levels 2-5 in 2020 (BH-adjusted-p = 0.014-0.042), concentrated in the first half of 2020, not persisting into 2021. Effect sizes declined with depth and the period effect was undetected in unrestricted ANOVA but significant with blocking (p = 0.017). Nine categories declined; only antidiabetics increased (A10BD; BH-adjusted p = 0.026). Kendall's W declined with depth (0.735 → 0.077). CONCLUSIONS: The pandemic was associated with a broad decline in pharmaceutical sales. Hierarchical ATC analysis revealed that aggregate patterns masked opposing movements. Monitoring sales at multiple ATC levels during emergencies is recommended. Limitations include non-random sampling, exclusion of online and hospital medications, and the inability to establish causality.

Schlagwörter

Stichwörter der Autor:innen

ATC classificationCOVID-19Turkeyhealth policyhierarchical analysispharmaceutical sales

Autor:innen und Institutionen

  • Biology Department, Faculty of Science, Karamanoğlu Mehmetbey University, Karaman, Turkey.
  • Department of Management Information Systems, Institute of Social Sciences, Karamanoğlu Mehmetbey University, Karaman, Turkey.

ORCID-Profile: Aytac Kocabas, Mehmet Cabir Akkoyunlu

Zitieren

APA

Kocabas, A., & Akkoyunlu, M. C. (2026). COVID-19 and pharmaceutical sales in Karaman, Turkey (2019–2021): a hierarchical ATC analysis. Expert Review of Pharmacoeconomics & Outcomes Research, 1-14. https://doi.org/10.1080/14737167.2026.2755202

Vancouver

Kocabas A, Akkoyunlu MC. COVID-19 and pharmaceutical sales in Karaman, Turkey (2019–2021): a hierarchical ATC analysis. Expert Review of Pharmacoeconomics & Outcomes Research. 2026:1-14. doi:10.1080/14737167.2026.2755202

BibTeX
@article{Kocabas2026,
  author = {Kocabas, Aytac and Akkoyunlu, Mehmet Cabir},
  title = {COVID-19 and pharmaceutical sales in Karaman, Turkey (2019–2021): a hierarchical ATC analysis},
  journal = {Expert Review of Pharmacoeconomics & Outcomes Research},
  year = {2026},
  pages = {1--14},
  doi = {10.1080/14737167.2026.2755202}
}
Kostenlos starten →